Plasma Concentrations of Monocyte Chemoattractant Protein 1 (MCP-1) and Neopterin in the Coronary Circulation of Patients with Coronary Artery Disease: Association with the Severity of Coronary Atherosclerosis

Circulation Journal

Volumn 68, Issue 2, 2004, Pages 114-120

  Tanaka, Takayuki ^a   Nakamura, Yuichi ^a   Nasuno, Akimitsu ^a   Mezaki, Tohru ^a   Higuchi, Koutarou ^a   Fukunaga, Hiroshi ^a   Tsuchida, Keiichi ^a   Ozaki, Kazuyuki ^a   Hori, Tomoyuki ^b   Matsubara, Taku ^b   Aizawa, Yoshifusa ^a  

^a NIIGATA UNIVERSITY GRADUATE SCHOOL OF MEDICAL AND DENTAL SCIENCES   (Japan)

^b Shinrakuen Hospital   (Japan)

Author keywords

Atherosclerosis; Coronary artery disease; Monocyte chemoattractant protein 1 (MCP 1); Neopterin

Indexed keywords

MONOCYTE CHEMOTACTIC PROTEIN 1; NEOPTERIN;

ADULT; AGED; ANGIOCARDIOGRAPHY; AORTA ROOT; ARTICLE; ATHEROSCLEROSIS; BLOOD SAMPLING; CORONARY ARTERY ATHEROSCLEROSIS; CORONARY ARTERY DISEASE; CORONARY SINUS; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; MACROPHAGE; MAJOR CLINICAL STUDY; MALE; MONOCYTE; PLASMA; SCORING SYSTEM;

ADULT; AGE FACTORS; AGED; BIOLOGICAL MARKERS; CHEMOKINE CCL2; CORONARY ARTERIOSCLEROSIS; CORONARY CIRCULATION; FEMALE; HUMANS; MALE; MIDDLE AGED; MONOCYTES; NEOPTERIN; SEVERITY OF ILLNESS INDEX;

EID: 10744226924     PISSN: 13469843     EISSN: None     Source Type: Journal    
DOI: 10.1253/circj.68.114     Document Type: Article

References (31)

1. Takeya M, Yoshimura T, Leonard EJ, Takahashi K. Detection of monocyte chemoattractant protein-1 in human atherosclerotic lesions by an anti-monocyte chemoattractant protein-1 monoclonal antibody. Hum Pathol 1993; 24: 534-539.
2. Nelken NA, Coughlin SR, Gordon D, Wilcox JN. Monocyte chemoattractant protein-1 in human atheromatous plaques. J Clin Invest 1991; 88: 1121-1127.
3. Yla-Herttuala S, Lipton BA, Rosenfeld ME, Sarkioja T, Yoshimura T, Leonard EJ, et al. Expression of monocyte chemoattractant protein-1 in macrophage-rich areas of human and rabbit atherosclerotic lesions. Proc Natl Acad Sci USA 1991; 88: 5252-5256.
4. Seino Y, Ikeda U, Takahashi M, Hojo Y, Irokawa M, Kasahara T, et al. Expression of monocyte chemoattractant protein-1 in vascular tissue. Cytokine 1995; 7: 575-579.
5. Jonasson L, Holm J, Skalli O, Bondjers G, Hansson GK. Regional accumulations of T cells, macrophages, and smooth muscle cells in the human atherosclerotic plaque. Arteriosclerosis 1986; 6: 131-138.
6. Jennifer RH. The role of MCP-1 in atherosclerosis. Stem Cells 2000; 18: 65-66.
7. Aiello RJ, Bourassa PA, Lindsey S, Weng W, Natoli E, Rollins BJ, et al. Monocyte chemoattractant protein-1 accelerates atherosclerosis in apolipoprotein E-deficient mice. Arterioscler Thromb Vasc Biol 1999; 19: 1518-1525.
8. Reckless J, Rubin EM, Verstuyft JB, Metcalfe JC, Grainger DJ. Monocyte chemoattractant protein-1 but not tumor necrosis factor-alpha is correlated with monocyte infiltration in mouse lipid lesions. Circulation 1999; 99: 2310-2316.
9. Porreca E, Di Febbo C, Reale M, Castellani ML, Baccante G, Barbacane R, et al. Monocyte chemotactic protein 1 (MCP-1) is a mitogen for cultured rat vascular smooth muscle cells. J Vasc Res 1997; 34: 58-65.
10. Boring L, Gosling J, Cleary M, Charo IF. Decreased lesion formation in CCR2-/- mice reveals a role for chemokines in the initiation of atherosclerosis. Nature 1998; 394: 894-897.
11. Huber C, Batchelor JR, Fuchs D, Hausen A, Lang A, Niederwieser D, et al. Immune response-associated production of neopterin: Release from macrophages primarily under control of interferon-gamma. J Exp Med 1984; 160: 310-316.
12. Berdowska A, Zwirska-Korczala K. Neopterin measurement in clinical diagnosis. J Clin Pharm Ther 2001; 26: 319-329.
13. Neumann FJ, Marx N, Gawaz M, Brand K, Ott I, Rokitta C, et al. Induction of cytokine expression in leukocytes by binding of thrombin-stimulated platelets. Circulation 1997; 95: 2387-2394.
14. Zhang T, Koide N, Wada Y, Tsukioka K, Takayama K, Kono T, et al. Significance of rronocyte chemotactic protein-1 and thymidine phosphorylase in angiogenesis of human cardiac myxoma. Circ J 2003; 67: 54-60.
15. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 1997; 20: 1183-1197.
16. Hori T, Matsubara T, Ishibashi T, Yamazoe M, Ida T, Higuchi K, et al. Decrease of nitric oxide end-products during coronary circulation reflects elevated basal coronary artery tone in patients with vasospastic angina. Jpn Heart J 2000; 41: 583-595.
17. Nasuno A, Matsubara T, Hori T, Higuchi K, Imai S, Nakagawa I, et al. Levels of soluble β-selectin and ICAM-1 in the coronary circulation of patients with stable coronary artery disease: Association with the severity of coronary atherosclerosis. Jpn Heart J 2002; 43: 93-101.
18. Gensini GG. A more meaningful scoring system for determining the severity of coronary heart disease. Am J Cardiol 1983; 51: 606.
19. Ueda A, Ishigatsubo Y, Okubo T, Yoshimura T. Transcriptional regulation of the human monocyte chemoattractant protein-1 gene: Cooperation of two NF-kappa B sites and NF-kappa B/Rel subunit specificity. J Biol Chem 1997; 272: 31092-31099.
20. Nishiyama K, Ogawa H, Yasue H, Soejima H, Misumi K, Takazoe K, et al. Simultaneous elevation of the levels of circulating monocyte chemoattractant protein-1 and tissue factor in acute coronary syndromes. Jpn Circ J 1998; 62: 710-712.
21. Hojo Y, Ikeda U, Takahashi M, Shimada K. Increased levels of monocyte-related cytokines in patients with unstable angina. Atherosclerosis 2002; 161: 403-408.
22. Schumacher M, Halwachs G, Tatzber F, Fruhwald FM, Zweiker R, Watzinger N, et al. Increased neopterin in patients with chronic and acute coronary syndromes. J Am Coll Cardiol 1997; 30: 703-707.
23. Gupta S, Fredericks S, Schwartzman RA, Holt DW, Kaski JC. Serum neopterin in acute coronary syndromes. Lancet 1997; 349: 1252-1253.
24. Melichar B, Gregor J, Solichova D, Lukes J, Tichy M, Pidrman V. Increased urinary neopterin in acute myocardial infarction. Clin Chem 1994; 40: 338-339.
25. Moreno PR, Falk E, Palacios IF, Newell JB, Fuster V, Fallon JT. Macrophage infiltration in acute coronary syndromes: Implications for plaque rupture. Circulation 1994; 90: 775-778.
26. Falk E. Morphological features of unstable atherothrombotic plaques underlying acute coronary syndromes. Am J Cardiol 1989; 63: 114E-120E.
27. Serneri GG, Abbate R, Gori AM, Attanasio M, Martini F, Giusti B, et al. Transient intermittent lymphocyte activation is responsible for the instability of angina. Circulation 1992; 86: 790-797.
28. Neri Serneri GG, Prisco D, Martini F, Gori AM, Brunelli T, Poggesi L, et al. Acute T-cell activation is detectable in unstable angina. Circulation 1997; 95: 1806-1812.
29. Libby P. Molecular bases of the acute coronary syndromes. Circulation 1995; 91: 2844-2850.
30. Oshima S, Ogawa H, Hokimoto S, Nakamura S, Noda K, Saito T, et al. Plasma monocyte chemoattractant protein-1 antigen levels and the risk of restenosis after coronary stent implntation. Jpn Circ J 2001; 65: 261-264.
31. Hokimoto S, Oike Y, Saito T, Kitaoka M, Oshima S, Noda K, et al. Increased expression of monocyte chemoattractant protein-1 in atherectomy specimens from patients with restenosis after percutaneous transluminal coronary angioplasty. Circ J 2002; 66: 114-116.